US prescription drug spending is forecast to exceed $560bn in 2026 as demand for GLP-1 obesity and diabetes treatments continues to rise.
You must be a subscriber to access all of this content.
iDexis semaglutide ban stops the pharmacy group from selling compounded weight-loss medicines while SAHPRA and the SAPC investigate.
You must be a subscriber to access all of this content.
SA's PEPFAR funding could end as the FW de Klerk Foundation urges Donald Trump to protect vital HIV services and infrastructure.
You must be a subscriber to access all of this content.
Contraceptive shortages hit South Africa following Aspen's manufacturing issues, prompting alternatives for the public health sector.
You must be a subscriber to access all of this content.
Medical scheme clawbacks remain lawful after the High Court rejected a challenge to Section 59(3) of the Medical Schemes Act.
You must be a subscriber to access all of this content.